Sanofi to Acquire Assets from Inhibrx in $2.2 Billion Deal
Sanofi, a leading pharmaceutical company, has announced its plans to purchase assets from biopharmaceutical company Inhibrx in a significant deal ...
Tag: Sanofi
Sanofi Releases Positive Trial Results for Investigational Eczema Treatment
Sanofi, a leading pharmaceutical company, has announced encouraging trial results for its investigational eczema treatment. This breakthrough comes as a ...
Sanofi Raises 2023 Guidance and Beats Expectations
Sanofi, the French pharmaceutical company, has recently announced an upward revision in its 2023 guidance and reported better-than-expected adjusted earnings ...
